HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wei Zhao Selected Research

Teniposide (VM 26)

6/2021[Research progress in biosynthesis of podophyllotoxin and its derivatives].
1/2021Challenges and potential for improving the druggability of podophyllotoxin-derived drugs in cancer chemotherapy.
1/2020Discovery of 4,6-O-Thenylidene-β-d-glucopyranoside-(2″-acetamido, 3″-acetyl-di-S-5-fluorobenzothizole/5-fluorobenzoxazole)-4'-demethylepipodophyllotoxin as Potential Less Toxic Antitumor Candidate Drugs by Reducing DNA Damage and Less Inhibition of PI3K.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Wei Zhao Research Topics

Disease

476Neoplasms (Cancer)
12/2022 - 05/2002
95Infections
10/2022 - 05/2003
84Neoplasm Metastasis (Metastasis)
02/2022 - 11/2003
76Inflammation (Inflammations)
09/2022 - 05/2006
67Breast Neoplasms (Breast Cancer)
01/2022 - 11/2003
61Hepatocellular Carcinoma (Hepatoma)
01/2022 - 05/2006
59Carcinogenesis
09/2022 - 01/2002
49Stomach Neoplasms (Stomach Cancer)
01/2022 - 01/2005
38Body Weight (Weight, Body)
02/2022 - 04/2010
37Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
09/2022 - 01/2010
37Lung Neoplasms (Lung Cancer)
01/2022 - 10/2002
36Alzheimer Disease (Alzheimer's Disease)
06/2022 - 08/2006
35Hypoxia (Hypoxemia)
08/2022 - 10/2008
31Osteosarcoma (Osteogenic Sarcoma)
01/2022 - 05/2011
28COVID-19
10/2022 - 01/2020
26Hypertension (High Blood Pressure)
05/2022 - 11/2007
24Glioma (Gliomas)
12/2022 - 10/2005
24Prostatic Neoplasms (Prostate Cancer)
06/2022 - 06/2002
24Obesity
02/2022 - 05/2010
24Myocardial Infarction
01/2022 - 11/2006
23Insulin Resistance
09/2022 - 01/2009
22Fibrosis (Cirrhosis)
10/2022 - 08/2002
21Type 2 Diabetes Mellitus (MODY)
01/2022 - 01/2009
21Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 01/2010
21Carcinoma (Carcinomatosis)
01/2021 - 09/2005
18Chronic Hepatitis B
06/2021 - 05/2003
18Spinal Cord Injuries (Spinal Cord Injury)
01/2021 - 01/2011
17Sepsis (Septicemia)
02/2022 - 02/2013
17Adenocarcinoma
01/2022 - 12/2008
17Coronary Disease (Coronary Heart Disease)
01/2022 - 11/2012
17Pain (Aches)
01/2022 - 10/2011
17Reperfusion Injury
01/2022 - 05/2005
17Liver Neoplasms (Liver Cancer)
12/2021 - 05/2006
16Cognitive Dysfunction
06/2022 - 01/2009
16Diabetes Mellitus
01/2022 - 03/2005
16Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 01/2013
16Adenocarcinoma of Lung
01/2021 - 09/2013
15Nasopharyngeal Carcinoma
01/2022 - 11/2009
15Atherosclerosis
01/2022 - 01/2007
15Pneumonia (Pneumonitis)
12/2021 - 04/2010
15Virus Diseases (Viral Diseases)
11/2021 - 04/2011
14Necrosis
01/2022 - 08/2002
14Ovarian Neoplasms (Ovarian Cancer)
01/2022 - 01/2011
14Glioblastoma (Glioblastoma Multiforme)
12/2021 - 09/2011
14Hemorrhage
11/2021 - 11/2005
14Squamous Cell Carcinoma of Head and Neck
06/2020 - 02/2013
13Wounds and Injuries (Trauma)
07/2022 - 02/2007
13Osteoporosis
06/2022 - 07/2010
13Coronary Artery Disease (Coronary Atherosclerosis)
01/2022 - 12/2012
13Hepatitis B
12/2021 - 04/2002
11Human Influenza (Influenza)
12/2022 - 06/2005
11Urinary Bladder Neoplasms (Bladder Cancer)
06/2022 - 03/2009

Drug/Important Bio-Agent (IBA)

197Proteins (Proteins, Gene)FDA Link
09/2022 - 08/2003
97Biomarkers (Surrogate Marker)IBA
12/2022 - 09/2005
95Pharmaceutical PreparationsIBA
10/2022 - 06/2002
74MicroRNAs (MicroRNA)IBA
06/2022 - 06/2010
72Messenger RNA (mRNA)IBA
09/2022 - 05/2006
63Biological ProductsIBA
08/2022 - 05/2002
51Long Noncoding RNAIBA
01/2022 - 03/2014
39RNA (Ribonucleic Acid)IBA
01/2022 - 09/2002
36LipidsIBA
09/2022 - 01/2007
34VaccinesIBA
10/2022 - 10/2005
34DNA (Deoxyribonucleic Acid)IBA
11/2021 - 05/2002
33CytokinesIBA
10/2022 - 05/2006
30Glucose (Dextrose)FDA LinkGeneric
01/2022 - 02/2010
25Small Interfering RNA (siRNA)IBA
10/2022 - 04/2008
25AntigensIBA
07/2022 - 10/2005
24EnzymesIBA
10/2022 - 04/2006
24Therapeutic UsesIBA
01/2022 - 10/2002
22Antiviral Agents (Antivirals)IBA
01/2022 - 12/2005
21Indicators and Reagents (Reagents)IBA
03/2022 - 05/2005
20Insulin (Novolin)FDA Link
10/2022 - 01/2009
19LipopolysaccharidesIBA
09/2022 - 02/2006
19Peptides (Polypeptides)IBA
01/2022 - 10/2010
18Anti-Bacterial Agents (Antibiotics)IBA
05/2022 - 03/2011
17Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
09/2022 - 10/2008
17Cisplatin (Platino)FDA LinkGeneric
01/2022 - 01/2012
17CateninsIBA
01/2022 - 04/2011
15Histones (Histone)IBA
06/2022 - 10/2003
15Triglycerides (Triacylglycerol)IBA
01/2022 - 03/2005
14Immunoglobulin G (IgG)IBA
08/2022 - 08/2002
14Reactive Oxygen Species (Oxygen Radicals)IBA
12/2021 - 03/2011
14Matrix Metalloproteinases (MMPs)IBA
08/2021 - 11/2003
13AntibodiesIBA
07/2022 - 06/2007
13Interleukin-6 (Interleukin 6)IBA
01/2022 - 03/2012
13C-Reactive ProteinIBA
01/2022 - 01/2013
12LigandsIBA
06/2022 - 11/2005
12CholesterolIBA
01/2022 - 03/2005
12Circular RNAIBA
01/2022 - 01/2018
12Blood Glucose (Blood Sugar)IBA
01/2022 - 10/2007
12Amyloid (Amyloid Fibrils)IBA
01/2020 - 08/2006

Therapy/Procedure

195Therapeutics
12/2022 - 05/2003
57Drug Therapy (Chemotherapy)
04/2022 - 10/2002
35Radiotherapy
01/2022 - 10/2010
24Immunotherapy
04/2022 - 10/2002
19Transplantation
01/2022 - 05/2002
18Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2022 - 10/2013
14Aftercare (After-Treatment)
01/2022 - 08/2002
13Percutaneous Coronary Intervention
01/2022 - 09/2008
12Lasers (Laser)
01/2022 - 04/2009